Abstract:Background: Depression is a common, chronic, and recurrent mood disorder that has become a worldwide health hazard. Fluoxetine hydrochloride, a common treatment method, can inhibit 5-hydroxytryptamine (5-HT) recycling in the presynaptic membrane; however, the efficacy of a single drug is inadequate. At present, mild-to-moderate depression can be treated with acupuncture of ghost caves, but the clinical curative effect of combined therapy with fluoxetine hydrochloride has not been sufficiently reported. Aim: To evaluate the clinical effect of acupuncture at ghost points combined with fluoxetine hydrochloride in the treatment of mild-to-moderate depression. Methods: This retrospective study included 160 patients with mild-to-moderate depression who were admitted to Shanghai Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated to Shanghai University of Traditional Chinese Medicine, between January 2022 and June 2023. Patients were separated into a single-agent group (fluoxetine hydrochloride treatment, n = 80) and a coalition group (fluoxetine hydrochloride treatment combined with acupuncture at ghost points, n = 80). Pre-treatment symptoms were recorded, and the clinical curative effect and adverse reactions [Asberg Antidepressant Side Effects Scale (SERS)] were assessed. Depression before and after treatment [Hamilton Depression Scale (HAMD)-24], neurotransmitter levels [5-HT, norepinephrine (NE), dopamine (DA)], oxidative stress indicators [superoxide dismutase (SOD), malondialdehyde (MDA)], and sleep quality [Pittsburgh Sleep Quality Index (PSQI)] were compared. Results: The total efficacy rate was 97.50% in the coalition group and 86.25% in the single-agent group (P < 0.05). After 2, 4, 6, and 8 wk of treatment, the HAMD, self-rating depression scale, and SERS scores of the coalition and single-agent groups decreased compared with pre-treatment, and the decrease was more significant in the coalition group (P < 0.05). After 8 wk of treatment, the levels of NE, DA, 5-HT, and SOD in the coalition and single-agent groups increased, while the levels of MDA decreased; the increases and decrease in the coalition group were more significant (P < 0.05). The PSQI scores of the coalition and single-agent groups decreased, and the decrease was more significant in the coalition group (P < 0.05). Conclusion: Acupuncture at ghost points combined with paroxetine tablets can safely improve depressive symptoms and sleep disorders, regulate neurotransmitter levels, and reduce stress responses in patients with mild-to-moderate depression.

Antidepressant treatment of elderly heart failure patients complicated with depressed in traditional Chinese medicine and Western Medicine

Randomized, Double Blind, Placebo-Controlled Trial of Shuganjieyu Capsule in the Treatment of Mild or Moderate Depression

Efficacy of Shuganjieyu Capsule for Treatment of Neurologic Disorders Combined with Depression: A Meta-Analysis

Effectiveness and safety of modified 'Huoxue Shugan' formulas on coronary heart disease combined with depression: protocol for a systematic review.

Clinical Research on Wuling Capsules Combined with Citalopram Hydrobromide Tablets Treating Elderly Patients with Depression and Insomnia

Efficacy and safety of double doses of SHUGANJIEYU capsules in treating moderate depressive disor-der:a multicenter, random, double-blind, and parallel-controlled trial

Evaluation of therapeutic markers and mechanism of Shuganjieyu capsule in treatment of depression

Efficacy and safety of Jinyukang capsules in the treatment of mild and moderate depression

Efficacy of fluoxetine combined with psychological intervention for treatment of depressive patients with insomnia

Clinical intervention effect of Xuefu Zhuyu decoction on chronic heart failure complicated with depression

[Low-Dose Tadalafil Combined with Shuganyiyang Capsules for Mild-to-moderate Erectile Dysfunction].

Clinical Investigatijon on Effect of Capsule of Wuling Combined with Citalopram in Treating Senile Depression

Improve Cognition of Depressive Patients Through the Regulation of Basal Ganglia Connectivity: Combined Medication Using Shuganjieyu Capsule.

Randomized,multicenter,double Blind Comparative Trial of Jin-yu-kang Capsule in the Treatment of Mild and Moderate Depression

A Randomized, Double-Blind, Positive-Controlled, Multicenter Clinical Trial on the Efficacy and Safety of ShuganJieyu Capsule and St. John's Wort for Major Depressive Disorder with Somatic Complaints

Efficacy and Safety of Anjiaxin Capsules in Treatment of Mild or Moderate Depression

Clinical effect of acupuncture at ghost points combined with fluoxetine hydrochloride on mild-to-moderate depression

Effect of Qihong Jieyu Decoction for Treatment of Chronic Heart Failure Complicated with Depression

Shugan Jieyu capsule effects on peripheral blood micro-124, micro-132, and brain-derived neurotrophic factor in patients with mild to moderate depression

Citalopram in the treatment of elderly chronic heart failure combined with depression: A systematic review and meta-analysis

Clinical Efficacy of Wuling Capsules in Treatment of Elderly Patients with Depression and Mild Cognitive Impairment